Members Login
Channels
Special Offers & Promotions
Thermo Fisher Scientific Fluorospectrometer Implemented by the University of California to improve the accuracy and efficiency of GFR Measurements in mice
Thermo Fisher
Scientific Inc., the world leader in serving science, today announced that the
University of California (UC), San Diego, Division of Nephrology/Hypertension
has implemented a Thermo Scientific NanoDrop 3300 Fluorospectrometer as the fluorescent
detection system for mouse glomerular filtration rate (GFR) determination. The Thermo
Scientific NanoDrop 3300 Fluorospectrometer offers a reliable micro-volume fluorescent
platform for repeated determination of GFR in conscious mice to assess their renal
function without surgical procedures. The instrument allows scientists to perform
these measurements simply, quickly and cost-effectively, making the instrument
a valuable tool for GFR research applications. A new application note entitled
‘Measuring Mouse GFR by Fluorescein
isothiocyanate (FITC)-Inulin using the Thermo Scientific NanoDrop 3300
Fluorospectrometer', is available for download at http://www.nanodrop.com/3300apps.html
UC San Diego's Division of Nephrology/Hypertension considers GFR measurement to be the most reliable method in renal function assessment and as such the technique is utilized by the team to determine GFR under physiological and pathophysiological conditions in mice. In the past, the division determined GFR by measuring radioactively labeled inulin in blood plasma and urine in anesthetized animals. However, anesthesia has multiple effects on the physiology of the mammalian body and repetitive measurements are difficult to perform. As this limitation significantly impacted the study designs, the division sought an alternative method.
UC San Diego's Division of Nephrology/Hypertension has implemented the Thermo Scientific NanoDrop 3300 fluorospectrometer to enable the measurement of GFR using FITC-inulin. This protocol retains the sensitivity of the traditional assay by using fluorescence detection, while the instrument's microvolume technology has enabled researchers to reduce the volumes of blood required to <10 μl per collection time point. The NanoDrop 3300 uses a patented "cuvette-less" sample retention system for fluorescence measurements using samples as small as 1-2 μl. This enables the division to undertake studies using serial measurements from the same model without compromising the accuracy of the GFR measurement data, or the health of the model. In addition, the easy-to-use instrument is capable of analyzing multiple emission profiles from a single sample and has a small footprint, taking up minimal space in the laboratory.
Dr. Timo Rieg, Assistant Professor of Medicine at UC San Diego, comments, "The productivity and accuracy of GFR measurements within the Division of Nephrology has been significantly enhanced. By combining the sensitivity of the FITC-Inulin technique with the microvolume format of the NanoDrop 3300 instrument, required blood volumes have been reduced. This reduction in blood draw and the possibility to measure GFR under conscious conditions have facilitated further studies in mice that until now were not possible because of the physiological effects of anesthesia and the terminal nature of other methods of GFR determination."
For further information on the University of California, San Diego, please visit http://nephrology.ucsd.edu/
For more information on the Thermo Scientific NanoDrop products and the free trial program, please visit www.thermoscientific.com/nanodrop or call +1 302-479-7707.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.
UC San Diego's Division of Nephrology/Hypertension considers GFR measurement to be the most reliable method in renal function assessment and as such the technique is utilized by the team to determine GFR under physiological and pathophysiological conditions in mice. In the past, the division determined GFR by measuring radioactively labeled inulin in blood plasma and urine in anesthetized animals. However, anesthesia has multiple effects on the physiology of the mammalian body and repetitive measurements are difficult to perform. As this limitation significantly impacted the study designs, the division sought an alternative method.
UC San Diego's Division of Nephrology/Hypertension has implemented the Thermo Scientific NanoDrop 3300 fluorospectrometer to enable the measurement of GFR using FITC-inulin. This protocol retains the sensitivity of the traditional assay by using fluorescence detection, while the instrument's microvolume technology has enabled researchers to reduce the volumes of blood required to <10 μl per collection time point. The NanoDrop 3300 uses a patented "cuvette-less" sample retention system for fluorescence measurements using samples as small as 1-2 μl. This enables the division to undertake studies using serial measurements from the same model without compromising the accuracy of the GFR measurement data, or the health of the model. In addition, the easy-to-use instrument is capable of analyzing multiple emission profiles from a single sample and has a small footprint, taking up minimal space in the laboratory.
Dr. Timo Rieg, Assistant Professor of Medicine at UC San Diego, comments, "The productivity and accuracy of GFR measurements within the Division of Nephrology has been significantly enhanced. By combining the sensitivity of the FITC-Inulin technique with the microvolume format of the NanoDrop 3300 instrument, required blood volumes have been reduced. This reduction in blood draw and the possibility to measure GFR under conscious conditions have facilitated further studies in mice that until now were not possible because of the physiological effects of anesthesia and the terminal nature of other methods of GFR determination."
For further information on the University of California, San Diego, please visit http://nephrology.ucsd.edu/
For more information on the Thermo Scientific NanoDrop products and the free trial program, please visit www.thermoscientific.com/nanodrop or call +1 302-479-7707.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.
Media Partners